ADAM17 and ovarian carcinoma: ADAM17 promotes the malignant progression of ovarian cancer and causes chemo-resistance by mediating ADAM17-dependent shedding of AREG, HB-EGF, IL-6Rα, TNF, TNFR1-α, TGFα and activating the EGFR signaling pathway (198, 200).